Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine
This study has been completed.
Study NCT00127855   Information provided by GlaxoSmithKline
First Received: August 8, 2005   Last Updated: October 30, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Haemophilus Infection
Meningococcal Infection
Additional conditions recognized in this trial
Communicable Diseases
Haemophilus Infections
Infection
Meningococcal Infections
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Neisseriaceae Infections
Pasteurellaceae Infections
Interventions listed in this trial
Hib-MenCY-TT vaccine
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services